OCTEVY

Serial Number 97026754
734

Registration Progress

Application Filed
Sep 14, 2021
Under Examination
Jul 28, 2022
Approved for Publication
May 31, 2022
Published for Opposition
May 31, 2022
Registered

Trademark Image

OCTEVY

Basic Information

Serial Number
97026754
Filing Date
September 14, 2021
Published for Opposition
May 31, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jul 29, 2025
Application
Pending
Classes
005

Rights Holder

Evergreen Theragnostics, Inc.

03
Address
27 Commerce Street
Springfield, NJ 07081

Ownership History

Evergreen Theragnostics, Inc.

Original Applicant
03
Springfield, NJ

Evergreen Theragnostics, Inc.

Owner at Publication
03
Springfield, NJ

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

41 events
Date Code Type Description Documents
Jul 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 29, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 22, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 28, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 23, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 23, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 23, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 23, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 23, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 15, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 15, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 16, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 16, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 16, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 16, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 16, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 16, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 10, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 10, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
May 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 29, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 17, 2022 NEWN I NEW NOA TO ISSUE Loading...
Jul 26, 2022 IUCN S NOTICE OF ALLOWANCE CANCELLED Loading...
Jul 28, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 31, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 31, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 11, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 27, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 27, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Apr 27, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Apr 27, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Apr 20, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 20, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 17, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical preparations; Diagnostic Radiopharmaceuticals agents for use in the field of nuclear medicine; Radiopharmaceuticals agents for use in the field of nuclear medicine, intended for medical imaging; Injectable diagnostic radiopharmaceutical agents; Diagnostic radiopharmaceutical agents for use in PET imaging; Radiopharmaceutical imaging and detection agents for diagnosing and monitoring cancer; Radiopharmaceutical preparations, in particular gallium coordination complexes and gallium DOTATOC for detecting cancer; Cold kit being gallium coordination complexes and gallium DOTATOC for use in imaging of neuroendocrine tumors

Classification

International Classes
005